Increased bone mineral density in a subset of patients with relapsed multiple myeloma who received the combination of bortezomib, dexamethasone and zoledronic acid — Evangelos Terpos (2010) | RDL Network
Increased bone mineral density in a subset of patients with relapsed multiple myeloma who received the combination of bortezomib, dexamethasone and zoledronic acid
David S. Siegel, Paul G. Richardson, Meletios A Dimopoulos, Philippe Moreau, C Mitsiades, D. Weber, Jennifer Houp, Christine K. Gause, Scott Vuocolo, Joe Eid, Thorsten Graef, Kenneth C. Anderson
Ajay K. Nooka, Keith Stockerl‐Goldstein, Hang Quach, Adam Forbes, María‐Victoria Mateos, Amit Khot, Alan Tan, Rafat Abonour, Bikramjit Chopra, Rachel Rogers, Geraldine Ferron‐Brady, Jacqueline Davidge, Steve Frey, Anne Yeakey, Mala K. Talekar, Katarina Luptakova, Ira Gupta, Rakesh Popat
Jesús F. San Miguel, Philippe Moreau, Sung‐Soo Yoon, Meletios A Dimopoulos, Vânia Hungria, W Wiktor-Jędrzejczak, Ashraf El Ghandour, Paolo Corradini, Andreas Günther, Meral Beksaç, Kwee Yong, Jae Hoon Lee, Sagar Lonial, Jian Hou, Hermann Einsele, Monika M Wroclawska-Swacha, Hans‐Jochen Weber, Priscille Bourquelot, Paul G. Richardson
Discussion(0)
No comments yet. Be the first to comment.